Loading…
FOLIC ACID is a brand name for Folic Acid. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Folic acid is indicated for the treatment of megaloblastic anaemia due to folic acid deficiency. It is also used for prophylaxis in chronic haemolytic states, in renal dialysis, and in drug induced folate deficiency. Folic acid is used for the prevention of recurrence of neural tube defects.
Verbatim from this product's MHRA label. Tap a section to expand.
Adults In folate deficient megaloblastic anaemia: 5mg daily for 4 months Up to 15mg daily may be necessary for malabsorption states For prophylaxis in chronic haemolytic states or in renal dialysis: 5mg every 1-7 days depending on diet and underlying disease.
In drug induced folate deficiency: 5mg daily Prevention of recurrence of neural tube defects 5mg daily starting before conception and continuing throughout the first trimester of pregnancy is recommended.
Children Over 1 year:
As adult dose Up to 1 year: 500μg/kg daily Method of administration The tablets are for oral use.
Folic acid is generally well tolerated although the following side effects have been reported: Blood and lymphatic system disorders: Folic acid may worsen the symptoms of co-existing vitamin B12 deficiency and should never be used to treat anaemia without a full investigation of the cause.
Immune system disorders:
Rare: Allergic reactions, comprising erythema, rash, pruritus, urticarial, dyspnoea.
Not Known; anaphylactic reactions Gastrointestinal disorder:
Abdominal distension, flatulence, anorexia and nausea. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Folic acid should not be administered for treatment of pernicious anaemia or undiagnosed megaloblastic anaemia without sufficient amounts of cyanocobalamin (vitamin B12) as folic acid alone will not prevent and may precipitate development of subacute combined degeneration of the spinal cord.
Therefore a full clinical diagnosis should be made before initiating treatment. Folate should not be routinely used in patients receiving coronary stents. Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
Folic acid is removed by haemodialysis.
1. Patients with malignant disease, unless megaloblastic anaemia due to folic acid deficiency.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Folic Acid in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.